Cargando…

Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe

Subsequent neoplasms (SNs) compromise long-term survivors after hematopoietic cell transplantation. We performed a retrospective analysis of SNs in 10 358 recipients of umbilical cord blood transplantation (UCBT) from 1988 to 2018. SNs developed in 233 patients and 84 were of pediatric age. Indicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rafii, Hanadi, Ruggeri, Annalisa, Kenzey, Chantal, Sanz, Jaime, Peffault De La Tour, Régis, Esquirol, Albert, Michel, Gérard, Chevallier, Patrice, Rubio, Marie-Thérèse, Cornelissen, Jan J., Michallet, Mauricette, Volt, Fernanda, Rivera-Franco, Monica M., Scigliuolo, Graziana Maria, Cappelli, Barbara, Rocha, Vanderson, Gluckman, Eliane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189403/ https://www.ncbi.nlm.nih.gov/pubmed/36350759 http://dx.doi.org/10.1182/bloodadvances.2022007941

Ejemplares similares

Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies
por: Fatobene, Giancarlo, et al.
Publicado: (2023)

Use of letermovir in umbilical cord blood transplantation based on risk scores
por: Rivera Franco, Monica M., et al.
Publicado: (2023)

Unrelated Donor Cord Blood Transplantation in Children: Lessons Learned Over 3 Decades
por: Kurtzberg, Joanne, et al.
Publicado: (2023)

PB1752: ANALYSIS OF HLA-PEPTIDE BINDING POCKETS IN PATIENTS WITH ACUTE LEUKEMIA UNDERGOING UMBILICAL CORD BLOOD TRANSPLANTATION
por: Boukouaci, W., et al.
Publicado: (2022)

HLA haplotype frequencies and diversity in patients with hemoglobinopathies
por: Scigliuolo, Graziana M., et al.
Publicado: (2023)

Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review
por: Tamouza, Ryad, et al.
Publicado: (2022)

Use of the HLA-B leader to optimize cord blood transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2020)

Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)
por: Rafii, Hanadi, et al.
Publicado: (2021)

Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease
por: Tozatto-Maio, Karina, et al.
Publicado: (2020)

Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks
por: Rafii, Hanadi, et al.
Publicado: (2017)

Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study
por: Gangneux, Jean-Pierre, et al.
Publicado: (2020)

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022)

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
por: Wagner, John E., et al.
Publicado: (2021)

Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)
por: Rafii, Hanadi, et al.
Publicado: (2021)

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study
por: Fein, Joshua A., et al.
Publicado: (2023)

Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report
por: Balas, Nora, et al.
Publicado: (2023)

Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation
por: Nunez, Lina, et al.
Publicado: (2022)

In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study
por: Devillier, Raynier, et al.
Publicado: (2022)

Activation status dictates the function of unlicensed natural killer cells in mice and humans
por: Aguilar, Ethan G., et al.
Publicado: (2021)

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
por: Clerici, Daniela, et al.
Publicado: (2022)

Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia
por: Saison, Julien, et al.
Publicado: (2014)

RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT
por: Baron, Frédéric, et al.
Publicado: (2016)

Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device
por: Wojciechowski, Joel C, et al.
Publicado: (2008)

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
por: Abramowicz, Daniel, et al.
Publicado: (2008)

Risk factors for polyoma virus nephropathy
por: Prince, Olivier, et al.
Publicado: (2009)

Benefit of kidney transplantation beyond 70 years of age
por: Heldal, Kristian, et al.
Publicado: (2010)

Pancreas transplantation: differences in activity between Europe and the United States
por: Manuel González-Posada, José, et al.
Publicado: (2009)

Improvement in kidney transplantation in the Balkans after the Istanbul Declaration: where do we stand today?
por: Spasovski, Goce, et al.
Publicado: (2016)

Reciprocating living kidney donor generosity: tax credits, health insurance and an outcomes registry
por: Joshi, Shivam, et al.
Publicado: (2016)

A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants
por: Jardine, Laura, et al.
Publicado: (2015)

Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015)

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
por: Vickers, Mark A, et al.
Publicado: (2014)

BK polyoma virus infection and renal disease in non-renal solid organ transplantation
por: Kuppachi, Sarat, et al.
Publicado: (2016)

Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure
por: Hougardy, Jean-Michel, et al.
Publicado: (2016)

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning
por: Townsend, William M, et al.
Publicado: (2013)

Identification of a Patient Population Previously Not Considered for Organ Donation
por: Barrois, Brad
Publicado: (2016)

Liver Transplantation after Exertional Heatstroke-Induced Acute Liver Failure
por: Inayat, Faisal, et al.
Publicado: (2016)

An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient
por: Ibrahim, Uroosa, et al.
Publicado: (2016)

Outcomes of living kidney donors with medullary sponge kidney
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

An observational study of health literacy and medication adherence in adult kidney transplant recipients
por: Demian, Maryam N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a1j4i4s93u1qklsmo5lkh65nl6